BVP portfolio company Healthplus.ai has joined the October 2026 cohort of Mayo Clinic Platform Accelerate, the largest cohort in the program’s history. Of the 31 companies, six were selected for the multiyear pathway, Healthplus.ai among them. The other 25 follow the 30-week accelerator track. Since its launch in 2022, Accelerate has supported more than 130 companies worldwide.
The multiyear pathway gives Healthplus.ai up to two years of access to Mayo Clinic Platform’s de-identified clinical data environment, its advisors and ongoing technical support. The aim is to develop PERISCOPE® further and prepare it for deployment in US clinical practice. For Healthplus.ai, this is a meaningful step on its path to the US market.
The clinical problem is late detection. Infections are among the most frequent complications after surgery, and they are often recognised only once symptoms appear. That leads to readmissions, longer hospital stays and extra costs. PERISCOPE is a CE-certified AI medical device that predicts which patients will develop an infection after surgery, days before symptoms appear. It runs inside the hospital’s electronic health record and uses data the hospital already collects. This lets surgical teams act earlier and plan discharge with more confidence.
About Healthplus.ai
Healthplus.ai helps surgical teams predict, detect and resolve complications early. Its first product is PERISCOPE®, a CE Class IIa certified AI medical device that predicts bacterial infections after surgery. Based in Amsterdam, the company aims to become the risk management platform for all surgeries. Healthplus.ai is a portfolio company of Brightlands Venture Partners.
About Mayo Clinic Platform Accelerate
Mayo Clinic Platform is a strategic initiative of Mayo Clinic that brings together data, AI development and clinical expertise to transform healthcare. Its Accelerate program supports health technology companies in developing and deploying their solutions. Companies get access to de-identified clinical data, mentorship from Mayo Clinic experts and technical support, through either a 30-week accelerator track or a multiyear pathway.
